Cipla reported INR61.6B in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
aTyr Pharma USD 2.79M 67.83K Mar/2026
Cara Therapeutics USD 900K 0 Mar/2025
Cipla INR 61.6B 5.18B Sep/2025
Dr.Reddys Laboratories INR 79.01B 3.19B Dec/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Sun Pharmaceuticals INR 102.43B 3.08B Mar/2025
TherapeuticsMD USD 6.7M 551K Sep/2022
UPL INR 161.93B 58.77B Sep/2025